🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The shining star of our family has dimmed his light for us in the present world,” his family confirmed. “After a lengthy and brave battle with cancer, we are heartbroken to declare that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his pioneering modern soul style and collaborations with renowned musicians.

He released his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The album achieved the fourth spot on the R&B charts, went platinum soon after, and received several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his music career into the limelight. The record premiered at the top spot on both the R&B charts and the main album chart. He received two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal featured the artist, notably stripped down to his waist, performing directly into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a severe car crash that put him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with another No. 1 debut on the soul music rankings and a award for Top R&B Record.

Once more, in his own enigmatic way, D’Angelo made only a few public outings in the subsequent period.

The singer was scheduled as a headliner for the 2025 music event, but his appearance was canceled, citing an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the months before his death, he had reportedly been in the hospital for months and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the deadliest and least preventable forms of the illness, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his loved ones, but we are forever thankful for the heritage of extraordinarily moving songs he has left us,” his kin expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy impacts the pancreas, a small organ that generates the hormone insulin and plays an essential role in breaking down food, among other functions. The position and dimensions of the pancreas in the body make it more challenging to identify malignancy.

Although pancreatic cancer makes up only approximately three percent of malignancy cases annually in the U.S., it is responsible for seven percent of malignancy fatalities.

Nearly 70,000 individuals will be found to have pancreatic cancer and about 52,000 will succumb to the disease in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and poor treatment options, and a smaller window to make a meaningful impact on the well-being of patients,” said a medical oncologist.

Because pancreatic cancer rarely causes early symptoms, it’s frequently identified only after the disease is late-stage. Although a patient has symptoms they are often vague and may be confused with a several everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, apart from listening to your body and consulting your physician if there are unfamiliar signs,” explained a health expert.

Common symptoms of this disease encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in adults in the 65 to 75 range. However, many cancers, such as pancreatic cancer, have become increasingly prevalent in younger people.

“This disease diagnosed prior to fifty is deemed uncommon, yet alarmingly, clinicians are noticing a growing number of younger patients suffering from this disease,” said a specialist.

Genetic Background Impacts Disease Probability

In the absence of effective screening tools for pancreatic cancer, experts emphasized the importance of knowing your family’s cancer history. Some risk factors, such as smoking and obesity also have an influence in the onset of this disease.

African Americans have the highest incidence of this malignancy in the U.S. and are most likely to be diagnosed with inoperable cancer.

“The initial action toward lowering one’s risk of pancreatic cancer is assessing individual susceptibility. People should review their genetic background, genetic background, and health issues, such as blood sugar disease, chronic pancreatitis, or overweight that may raise their vulnerability,” advised a medical professional.

Hereditary risk factors are linked to as much as 10% of all pancreatic cancer instances. If a relative in your family has had pancreatic cancer, you may want to think about DNA analysis.

“For people with a relative’s background of pancreatic cancer or those carrying elevated risk genetic mutations, screening may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to detect early changes in the organ,” he clarified.

For those looking to lower their chance, lifestyle changes may have an effect. The best action you can take to lower your risk of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so limiting or avoiding drinks may help lower your chance.

Managing your weight or shedding pounds may also aid reduce your risk. People with obesity are 20% more likely to develop pancreatic cancer. This malignancy also occurs more often in people with blood sugar issues, and reducing weight can also reduce the risk of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer combination chemotherapy. There are emerging targeted therapies that are already making an impact,” remarked a expert.

For many individuals, however, awareness about this uncommon but {dev